{"id":"W2604788765","doi":"10.1200/jco.2009.27.15_suppl.6026","title":"A phase II randomized study of oral seliciclib in patients with previously treated nasopharyngeal carcinoma","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Clinical endpoint; Dosing; Phases of clinical research; Nasopharyngeal carcinoma; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Oncology; Randomized controlled trial; Surgery; Adverse effect; Clinical trial; Radiation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002455489,0.0001864549,0.00359264,0.0002150472,0.00002523592,0.000002514292,0.0001501021,0.0001808912,0.00005025004],"category_scores_gemma":[0.001227069,0.0001107999,0.0003224154,0.0002691149,0.0002023921,0.0001436497,0.00002371326,0.0007234352,9.351101e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001557847,"about_ca_system_score_gemma":0.000656557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004203124,"about_ca_topic_score_gemma":0.00004199763,"domain_scores_codex":[0.9952675,0.0008827174,0.002957931,0.0001999849,0.0004444435,0.0002474157],"domain_scores_gemma":[0.995718,0.0009343779,0.00224952,0.000208396,0.0006266194,0.0002630997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5509474,0.03631116,0.2627439,0.000007969608,0.0003665798,0.0003193495,0.0007175529,0.00001638831,0.00002251932,0.000004067366,0.00003058024,0.1485125],"study_design_scores_gemma":[0.5135035,0.1511114,0.3343481,0.00006838202,0.0004577558,0.00003673942,0.0001042457,0.00002394395,0.00002021439,0.00005509833,0.0002128756,0.00005769655],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972171,0.0002863245,0.00002752,0.0008777463,0.0001662492,0.001215451,0.000001808276,0.000008948355,0.000198901],"genre_scores_gemma":[0.9975107,0.00003229995,0.001402349,0.0007969475,0.0001841561,0.000007841068,0.000002652792,0.00001596414,0.00004704897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1484548,"threshold_uncertainty_score":0.4518289,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05884612129321212,"score_gpt":0.4440168656654185,"score_spread":0.3851707443722064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}